Understanding mechanisms and treatments for neuropathic disease

Affiliations

Comment

Katharine Harding et al. J Neurol. 2012 Jul.

. 2012 Jul;259(7):1509-11.

doi: 10.1007/s00415-012-6587-2.

¹ Department of Psychological Medicine and Neurology, Cardiff University, University Hospital of Wales, Cardiff, CF14 4XN, UK.

No abstract available

Comment on

Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy.
Harms MB, Ori-McKenney KM, Scoto M, Tuck EP, Bell S, Ma D, Masi S, Allred P, Al-Lozi M, Reilly MM, Miller LJ, Jani-Acsadi A, Pestronk A, Shy ME, Muntoni F, Vallee RB, Baloh RH. Harms MB, et al. Neurology. 2012 May 29;78(22):1714-20. doi: 10.1212/WNL.0b013e3182556c05. Epub 2012 Mar 28. Neurology. 2012. PMID: 22459677 Free PMC article.
Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study.
Echaniz-Laguna A, de Séze J, Chanson JB. Echaniz-Laguna A, et al. J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):699-705. doi: 10.1136/jnnp-2012-302374. Epub 2012 May 10. J Neurol Neurosurg Psychiatry. 2012. PMID: 22577230
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Nobile-Orazio E, Cocito D, Jann S, Uncini A, Beghi E, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Macchia R, Cavaletti G, Giannini F, Sabatelli M; IMC Trial Group. Nobile-Orazio E, et al. Lancet Neurol. 2012 Jun;11(6):493-502. doi: 10.1016/S1474-4422(12)70093-5. Epub 2012 May 10. Lancet Neurol. 2012. PMID: 22578914 Clinical Trial.